CCEB Seminar- Danping Liu, PhD

  Danping Liu, PhD Investigator National Cancer Institute Division of Cancer Epidemiology and Genetics Bethesda, MD   Dr. Liu is interested in developing new statistical methods to evaluate and combine biomarkers for use in risk prediction. Individualized disease risk prediction is particularly attractive to patients, health care providers and policy makers. At the population level, accurate prediction of disease helps target interventions and treatments to the most vulnerable groups. Biomarker research has attracted much attention in the diagnosis or prediction of disease outcomes, especially in studies of cancer. Particularly,